LabTech released its 2026 interim report on August 27, showing a slight decline in revenue and a sharp drop in profit for the period, while the company launched intelligent new products in semiconductor inspection and emerging pollutant treatment, further deepening its global footprint. The financial report shows the company achieved operating revenue of 190 million yuan, down 1.07% year on year; net profit attributable to the parent company was 13.37 million yuan, down 36.60% year on year; and net profit attributable to the parent company excluding non-recurring items was 11.13 million yuan, down 41.05% year on year. Overall gross margin was 46.05%, up 0.50 percentage points year on year. The decline in performance was mainly due to selling expenses rising 5.40% year on year, research and development expenses rising 15.28% year on year to account for 14.34% of revenue, and credit impairment losses increasing by 2.58 million yuan year on year. The company's EvoLab intelligent full-process elemental analysis system and Genesis M1 high-throughput microplastics analysis system are expected to form new growth drivers in inorganic elemental analysis and emerging pollutant detection, but the company faces risks including intensifying market competition, raw material price fluctuations, and exchange rate movements.
Beijing LabTech Instruments Co LtdNet profit fell 36.6% due to higher expenses and credit losses.